Literature DB >> 304356

Importance of methodology in demonstrating depression of T-lymphocyte levels.

R H Whitehead, G P Roberts, L E Hughes, J Thatcher.   

Abstract

A comparison has been made of 3 methods of determining E rosettes in young, healthy people, women with breast cancer and an age-matched group of healthy women, in an attempt to explain the wide variations in T-cell levels in different disease states reported by different workers. The greatest difference in levels of E-rosetting cells between the different groups was seen in incubation of 1 1/2 h at 4 degrees C. Much of the difference seen in these comparisons disappeared after overnight incubation at 4 degrees C, which was associated with an increased T-cell level in all groups. Consequently, although maximal levels of T lymphocytes as determined by E rosetting are found using overnight incubation, a short incubation period may be superior for demonstrating subtle depressions in levels of T lymphocytes as seen in elderly people and cancer patients. This depression is not considered to be cancer specific, because of the findings in the age-matched control group and similar findings in benign disease states.

Entities:  

Mesh:

Year:  1978        PMID: 304356      PMCID: PMC2009503          DOI: 10.1038/bjc.1978.4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.

Authors:  T Nemoto; T Han; J Minowada; V Angkur; A Chamberlain; L Dao
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

2.  Thymus-derived rosette-forming cells.

Authors:  J Wybran; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-05-17       Impact factor: 91.245

3.  Rosette-forming T cells in human peripheral blood at different ages.

Authors:  E D Carosella; K Mochanko; M Braun
Journal:  Cell Immunol       Date:  1974-05       Impact factor: 4.868

4.  Age-related variation in proportion of circulating T cells.

Authors:  M A Smith; J Evans; C M Steel
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

5.  Letter: Decrease of T lymphocytes during ageing.

Authors:  W Augener; G Cohnen; A Reuter; G Brittinger
Journal:  Lancet       Date:  1974-06-08       Impact factor: 79.321

6.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

7.  Masking of receptors for sheep erythrocytes on human T-lymphocytes by sera from breast cancer patients.

Authors:  R H Whitehead; G P Roberts; J Thatcher; C Teasdale; L E Hughes
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

8.  Letter: Age dependence of T lymphocytes.

Authors:  C Teasdale; J Thatcher; R H Whitehead; L E Hughes
Journal:  Lancet       Date:  1976-06-26       Impact factor: 79.321

9.  T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro.

Authors:  R H Whitehead; J Thatcher; C Teasdale; G P Roberts; L E Hughes
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

10.  Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein.

Authors:  F V Chisari; T S Edgington
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  4 in total

1.  Prognostic significance of immunological tests in lung cancer.

Authors:  I J Check; R L Hunter; T Karrison; T R DeMeester; H M Golomb; J Vardiman
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

2.  Significance of tumour mass on T-lymphocyte levels in patients with gastrointestinal cancer.

Authors:  H S Shukla; R H Whitehead; L E Hughes
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

3.  E-rosette-forming cells at 29 degrees C: an assay for the evaluation of the immune status of cancer patients.

Authors:  P C Quan; P Burtin
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

4.  Antibody production in cultured blood lymphocytes from breast cancer patients.

Authors:  M L Villa; M Migliori; E Clerici
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.